Literature DB >> 8501131

Prospects for use of microgravity-based bioreactors to study three-dimensional host-tumor interactions in human neoplasia.

J M Jessup1, T J Goodwin, G Spaulding.   

Abstract

Microgravity offers unique advantages for the cultivation of mammalian tissues because the lack of gravity-induced sedimentation supports three-dimensional growth in batch culture in aqueous medium. Bioreactors that simulate microgravity but operate in unit gravity provide conditions that permit human epithelial cells to grow to densities approaching 10(7) cells/ml on microcarriers in suspension, in masses up to 1 cm in diameter, and under conditions of low shear stress. While useful for many different applications in tissue culture, this culture system is especially useful for the analysis of the microenvironment in which host matrix and cells interact with infiltrating tumor cells. Growth in the microgravity-based bioreactor has supported morphological differentiation of human colon carcinoma cells when cultured with normal human stromal cells. Furthermore, these co-cultures produced factors that stimulated goblet cell production in normal colon cells in an in vivo bioassay. Early experiments also suggest that the microgravity environment will not alter the ability of epithelial cells to recognize and associate with each other and with constituents of basement membrane and extracellular matrix. These findings suggest that cells grown in bioreactors that simulate aspects of microgravity or under actual microgravity conditions will produce tissues and substances in sufficient quantity and at high enough concentration to promote characterization of molecules that control differentiation and neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501131     DOI: 10.1002/jcb.240510308

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  31 in total

Review 1.  Fetal thymic organ culture in rotating bioreactors.

Authors:  B Tabourn; L M Spain
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

2.  Impairment of antigen-specific cellular immune responses under simulated microgravity conditions.

Authors:  K J Sastry; P N Nehete; C A Savary
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

3.  Simulated microgravity impairs respiratory burst activity in human promyelocytic cells.

Authors:  J H Hughes; J P Long
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

4.  Microarray analysis of genes differentially expressed in HepG2 cells cultured in simulated microgravity: preliminary report.

Authors:  V I Khaoustov; D Risin; N R Pellis; B Yoffe
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

5.  Modeled microgravity inhibits apoptosis in peripheral blood lymphocytes.

Authors:  D Risin; N R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

6.  Suppression of antigen-specific lymphocyte activation in modeled microgravity.

Authors:  D Cooper; M W Pride; E L Brown; D Risin; N R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

7.  Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?

Authors:  Giovanna Mazzoleni; D Di Lorenzo; N Steimberg
Journal:  Genes Nutr       Date:  2008-12-18       Impact factor: 5.523

8.  Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers.

Authors:  V Chopra; T V Dinh; E V Hannigan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

9.  Changes in gravity inhibit lymphocyte locomotion through type I collagen.

Authors:  N R Pellis; T J Goodwin; D Risin; B W McIntyre; R P Pizzini; D Cooper; T L Baker; G F Spaulding
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

Review 10.  Using space-based investigations to inform cancer research on Earth.

Authors:  Jeanne L Becker; Glauco R Souza
Journal:  Nat Rev Cancer       Date:  2013-04-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.